546 related articles for article (PubMed ID: 31013069)
21. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Atwood CS; Perry G; Zeng H; Kato Y; Jones WD; Ling KQ; Huang X; Moir RD; Wang D; Sayre LM; Smith MA; Chen SG; Bush AI
Biochemistry; 2004 Jan; 43(2):560-8. PubMed ID: 14717612
[TBL] [Abstract][Full Text] [Related]
22. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
[TBL] [Abstract][Full Text] [Related]
23. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
[TBL] [Abstract][Full Text] [Related]
24. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
La Penna G; Hureau C; Andreussi O; Faller P
J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
[TBL] [Abstract][Full Text] [Related]
25. The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques.
Jiang D; Zhang L; Grant GP; Dudzik CG; Chen S; Patel S; Hao Y; Millhauser GL; Zhou F
Biochemistry; 2013 Jan; 52(3):547-56. PubMed ID: 23237523
[TBL] [Abstract][Full Text] [Related]
26. Copper catalyzed oxidation of Alzheimer Abeta.
Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
[TBL] [Abstract][Full Text] [Related]
27. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.
Drew SC; Masters CL; Barnham KJ
PLoS One; 2010 Dec; 5(12):e15875. PubMed ID: 21209855
[TBL] [Abstract][Full Text] [Related]
29. ESEEM analysis of multi-histidine Cu(II)-coordination in model complexes, peptides, and amyloid-β.
Silva KI; Michael BC; Geib SJ; Saxena S
J Phys Chem B; 2014 Jul; 118(30):8935-44. PubMed ID: 25014537
[TBL] [Abstract][Full Text] [Related]
30. Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.
Tickler AK; Smith DG; Ciccotosto GD; Tew DJ; Curtain CC; Carrington D; Masters CL; Bush AI; Cherny RA; Cappai R; Wade JD; Barnham KJ
J Biol Chem; 2005 Apr; 280(14):13355-63. PubMed ID: 15668252
[TBL] [Abstract][Full Text] [Related]
31. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
32. Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form.
Sarell CJ; Syme CD; Rigby SE; Viles JH
Biochemistry; 2009 May; 48(20):4388-402. PubMed ID: 19338344
[TBL] [Abstract][Full Text] [Related]
33. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
34. Ligand-field and ligand-binding analysis of the active site of copper-bound Aβ associated with Alzheimer's disease.
Ghosh C; Dey SG
Inorg Chem; 2013 Feb; 52(3):1318-27. PubMed ID: 23330670
[TBL] [Abstract][Full Text] [Related]
35. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
Jiang D; Li X; Liu L; Yagnik GB; Zhou F
J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
[TBL] [Abstract][Full Text] [Related]
36. Key roles of Tyr 10 in Cu bound Aβ complexes and its relevance to Alzheimer's disease.
Lu N; Li J; Gao Z
Arch Biochem Biophys; 2015 Oct; 584():1-9. PubMed ID: 26247837
[TBL] [Abstract][Full Text] [Related]
37. pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.
Alies B; Eury H; Bijani C; Rechignat L; Faller P; Hureau C
Inorg Chem; 2011 Nov; 50(21):11192-201. PubMed ID: 21980910
[TBL] [Abstract][Full Text] [Related]
38. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
39. Ab initio model studies of copper binding to peptides containing a His-His sequence: relevance to the beta-amyloid peptide of Alzheimer's disease.
Raffa DF; Gómez-Balderas R; Brunelle P; Rickard GA; Rauk A
J Biol Inorg Chem; 2005 Dec; 10(8):887-902. PubMed ID: 16267663
[TBL] [Abstract][Full Text] [Related]
40. Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.
Parthasarathy S; Yoo B; McElheny D; Tay W; Ishii Y
J Biol Chem; 2014 Apr; 289(14):9998-10010. PubMed ID: 24523414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
